ציקלוסירין
הערות שוליים

1 2 3 4 5  Cycloserine Monograph for Professionals, Drugs.com (באנגלית)
↑  Gottlieb, David., Mechanism of Action, Berlin, Heidelberg: Springer Berlin Heidelberg, 1967
↑  Michael A. Nitsche, Wiebke Jaussi, David Liebetanz, Nicolas Lang, Consolidation of human motor cortical neuroplasticity by D-cycloserine, Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology 29, 2004-8, עמ' 1573–1578 doi: 10.1038/sj.npp.1300517
1 2  TOXNET, toxnet.nlm.nih.gov
↑  Rasmita Ori, Taryn Amos, Hanna Bergman, Karla Soares-Weiser, Augmentation of cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related disorders, The Cochrane Database of Systematic Reviews, 2015-05-10, עמ' CD007803 doi: 10.1002/14651858.CD007803.pub2
↑  Sebastian Schade, Walter Paulus, D-Cycloserine in Neuropsychiatric Diseases: A Systematic Review, The International Journal of Neuropsychopharmacology 19, 2016-4 doi: 10.1093/ijnp/pyv102
↑  Karyn M. Myers, William A. Carlezon, D-cycloserine effects on extinction of conditioned responses to drug-related cues, Biological Psychiatry 71, 2012-06-01, עמ' 947–955 doi: 10.1016/j.biopsych.2012.02.030
↑  M. P. Lambert, F. C. Neuhaus, Mechanism of D-cycloserine action: alanine racemase from Escherichia coli W, Journal of Bacteriology 110, 1972-6, עמ' 978–987
1 2 3  Gareth A. Prosser, Luiz Pedro S. de Carvalho, Kinetic mechanism and inhibition of Mycobacterium tuberculosis D-alanine:D-alanine ligase by the antibiotic D-cycloserine, The FEBS journal 280, 2013-2, עמ' 1150–1166 doi: 10.1111/febs.12108
↑  G. Kaushal, R. Ramirez, D. Alambo, W. Taupradist, Initial characterization of D-cycloserine for future formulation development for anxiety disorders, Drug Discoveries & Therapeutics 5, 2011-10, עמ' 253–260
1 2  Gregory T. Olson, Mengmeng Fu, Sharon Lau, Kenneth L. Rinehart, An Aromatization Mechanism of Inactivation of γ-Aminobutyric Acid Aminotransferase for the Antibiotic l-Cycloserine, Journal of the American Chemical Society 120, 1998-03-01, עמ' 2256–2267 doi: 10.1021/ja972907b
↑  Frederick A. Kuehl, Frank J. Wolf, Nelson R. Trenner, Robert L. Peck, D-4-AMINO-3-ISOXAZOLIDONE, A NEW ANTIBIOTIC*, Journal of the American Chemical Society 77, 1955-04-01, עמ' 2344–2345 doi: 10.1021/ja01613a105
↑  Charles H. Stammer, Andrew N. Wilson, Frederick W. Holly, Karl Folkers, SYNTHESIS OF D-4-AMINO-3-ISOXAZOLIDONE, Journal of the American Chemical Society 77, 1955-04-01, עמ' 2346–2347 doi: 10.1021/ja01613a107
↑  Phil H. Hidy, E. B. Hodge, Vernon V. Young, Roger L. Harned, Glenn A. Brewer, STRUCTURE AND REACTIONS OF CYCLOSERINE1, pubs.acs.org, ‏2002-05-01 (באנגלית)
↑  Michael M. Torrice,Chemical & Engineering News, Learning and Brain Activity Are Boosted by a Dose of a Small-Molecule Compound, Scientific American (באנגלית)
↑  Mallory E. Bowers, Kerry J. Ressler, An Overview of Translationally Informed Treatments for Posttraumatic Stress Disorder: Animal Models of Pavlovian Fear Conditioning to Human Clinical Trials, Biological Psychiatry 78, 2015-09-01, עמ' E15–27 doi: 10.1016/j.biopsych.2015.06.008
↑  N. Singewald, C. Schmuckermair, N. Whittle, A. Holmes, Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders, Pharmacology & Therapeutics 149, 2015-5, עמ' 150–190 doi: 10.1016/j.pharmthera.2014.12.004
↑  Donald C. Goff, D-cycloserine: an evolving role in learning and neuroplasticity in schizophrenia, Schizophrenia Bulletin 38, 2012-9, עמ' 936–941 doi: 10.1093/schbul/sbs012